179 related articles for article (PubMed ID: 28498427)
1. Effect of macrophages on breast cancer cell proliferation, and on expression of hormone receptors, uPAR and HER-2.
Lindsten T; Hedbrant A; Ramberg A; Wijkander J; Solterbeck A; Eriksson M; Delbro D; Erlandsson A
Int J Oncol; 2017 Jul; 51(1):104-114. PubMed ID: 28498427
[TBL] [Abstract][Full Text] [Related]
2. Macrophages of M1 phenotype have properties that influence lung cancer cell progression.
Hedbrant A; Wijkander J; Seidal T; Delbro D; Erlandsson A
Tumour Biol; 2015 Nov; 36(11):8715-25. PubMed ID: 26050228
[TBL] [Abstract][Full Text] [Related]
3. Human breast cancer cells educate macrophages toward the M2 activation status.
Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
[TBL] [Abstract][Full Text] [Related]
4. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
5. ERα-36 regulates progesterone receptor activity in breast cancer.
Konan HP; Kassem L; Omarjee S; Surmieliova-Garnès A; Jacquemetton J; Cascales E; Rezza A; Trédan O; Treilleux I; Poulard C; Le Romancer M
Breast Cancer Res; 2020 May; 22(1):50. PubMed ID: 32429997
[TBL] [Abstract][Full Text] [Related]
6. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
[TBL] [Abstract][Full Text] [Related]
7. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
8. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
10. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of steroid receptors (estrogen receptor alpha and/or progesterone receptors) and Her-2/neu: Clinical implications.
Ciocca DR; Gago FE; Fanelli MA; Calderwood SK
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):32-40. PubMed ID: 17049840
[TBL] [Abstract][Full Text] [Related]
13. Markers of progression and invasion in short term follow up of untreated breast cancer patients.
Rabi ZA; Todorović-Raković N; Vujasinović T; Milovanović J; Nikolić-Vukosavljević D
Cancer Biomark; 2015; 15(6):745-54. PubMed ID: 26406416
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Invasion and Metastasis by mPRα Through the PI3K/Akt Signaling Pathway.
Wu X; Sun L; Wang X; Su P; Li Z; Zhang C; Wang Y; Gao P; Ma R
Pathol Oncol Res; 2016 Jul; 22(3):471-6. PubMed ID: 26608797
[TBL] [Abstract][Full Text] [Related]
15. A novel culture method that sustains ERα signaling in human breast cancer tissue microstructures.
Cartaxo AL; Estrada MF; Domenici G; Roque R; Silva F; Gualda EJ; Loza-Alvarez P; Sflomos G; Brisken C; Alves PM; André S; Brito C
J Exp Clin Cancer Res; 2020 Aug; 39(1):161. PubMed ID: 32807212
[TBL] [Abstract][Full Text] [Related]
16. Potential clinical relevance of uPA and PAI-1 levels in node-negative, postmenopausal breast cancer patients bearing histological grade II tumors with ER/PR expression, during an early follow-up.
Buta M; Džodić R; Đurišić I; Marković I; Vujasinović T; Markićević M; Nikolić-Vukosavljević D
Tumour Biol; 2015 Sep; 36(10):8193-200. PubMed ID: 25994573
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
[TBL] [Abstract][Full Text] [Related]
18. A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogen.
Eastman BM; Jo M; Webb DL; Takimoto S; Gonias SL
Cell Signal; 2012 Sep; 24(9):1847-55. PubMed ID: 22617030
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 as a potential tumor marker in breast cancer.
Nanda DP; Sil H; Moulik S; Biswas J; Mandal SS; Chatterjee A
J Environ Pathol Toxicol Oncol; 2013; 32(2):115-29. PubMed ID: 24099425
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation.
Pedroza DA; Subramani R; Tiula K; Do A; Rashiraj N; Galvez A; Chatterjee A; Bencomo A; Rivera S; Lakshmanaswamy R
Lab Invest; 2021 Jun; 101(6):733-744. PubMed ID: 33903732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]